As a result of the collaboration between several research groups, it has been possible to develop the production of different SARS-CoV-2 proteins and their incorporation into diagnostic tests for seropositivity. The capacity of these antigens to detect the presence of antibodies against SARS-CoV-2 in serums of convalescent patients opens the way to the development of diagnostic tests to identify different stages of immunity in SARS-CoV-2 infected individuals, a key tool for epidemiological studies, to detect the presence of neutralizing antibodies or to temporarily monitor patients’ immunity. Very important aspects in the processes of de-escalation and return to the routine.
Principal Investigators: Francisco Rodríguez, Hugh Reyburn, Jose M. Casasnovas, José Miguel Rodríguez, Mar Vales (CNB)
COVID-19 Project. Centro Nacional de Biotecnología (CNB)-CSIC